Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma
Clinical trial NCT00294632 · COMPLETED
Trial details
- NCT number
- NCT00294632
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2016-02-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.